3650 results for «411»

Filter By

3650 results

CTO BASIC Level I: LIVE Educational Cases from Institut Cardiovasculaire Paris Sud, France & University Hospital Basel, Switzerland

20 May 2026 – From EuroPCR 2026

This educational session provides a foundational understanding of chronic total occlusions (CTO) through live case presentations from leading centers in Paris and Basel. It covers CTO pathophysiology, angiographic analysis, and essential technical skills including guide catheter support, wire escalation, and microcatheter use. The session aims to...

CTO BASIC Level I: LIVE Educational Cases from Institut Cardiovasculaire Paris Sud, France & University Hospital Basel, Switzerland

Innovative strategy in ACS

20 May 2026 – From EuroPCR 2026

Focusing on innovative strategies in acute coronary syndrome (ACS), this session reviews recent advances including drug-coated balloons in STEMI, early discharge safety guided by microcirculatory resistance indices, intravascular lithotripsy for coronary calcification in ACS, and novel stenting protocols demonstrated in randomized trials, providing a comprehensive update...

Innovative strategy in ACS

Complex PCI - Best cases from PCR Global Interventional Academy - Part 1

20 May 2026 – From EuroPCR 2026

This session presents some of the best complex PCI cases from the PCR Global Interventional Academy, highlighting challenging scenarios such as thrombus management, precision in left main interventions, dual left anterior descending artery anatomy, and tailored strategies for very complex left main PCI, accompanied by key...

Navigating complexity: contemporary approaches to multivessel disease

20 May 2026 – From EuroPCR 2026

This session addresses contemporary approaches to multivessel coronary artery disease, featuring functional assessments, microvascular resistance importance in chest pain despite normal angiography, management of guide catheter-induced intramural hematoma, drug-coated balloon strategies including dual CTO, and minimal contrast PCI techniques in patients with chronic renal failure.

TAVI in aortic regurgitation and large annulus

20 May 2026 – From EuroPCR 2026

Focusing on TAVI in patients with aortic regurgitation and large annulus, this session reviews clinical outcomes and advancements including aneurysm progression slowing, device regurgitation assessment by cardiac MRI, one-year results with Ken-valve, novel retrievable self-expanding valves, staging classifications, and balloon-expandable valve performance.

AI in imaging & the cathlab - opportunities in procedural planning & guidance

20 May 2026 – From EuroPCR 2026

This session explores the role of artificial intelligence in imaging and the cathlab, emphasizing computer vision applications distinct from language models. It discusses AI's integration into procedural planning and guidance, balancing algorithmic support with physician judgement to enhance interventional cardiology workflows.

Coronary innovations and artificial intelligence: new devices, smarter tools, better outcomes

20 May 2026 – From EuroPCR 2026

This session provides a practical update on emerging coronary innovations and AI technologies, including next-generation calcium modification devices, bioresorbable scaffolds, sirolimus drug-coated balloons, and AI-driven coronary physiology and imaging tools. It offers a roadmap for integrating these advancements into clinical practice, addressing technology selection, reimbursement, training,...

Tricuspid interventions: find the best candidate

20 May 2026 – From EuroPCR 2026

This session reviews the phenotypes of tricuspid regurgitation and their diagnostic pathways, emphasizing standardized and pragmatic diagnostic steps. It also addresses criteria for identifying optimal timing and candidates for tricuspid valve interventions.

Tricuspid interventions: find the best candidate

New TAVI platforms - Novel devices, early data

20 May 2026 – From EuroPCR 2026

Explore the latest developments in TAVI technology, featuring novel valve platforms and early clinical data. The session covers outcomes from new self-expandable and balloon-expandable valves, innovative single-operator techniques, redo TAVI approaches, and advances in CT sizing powered by deep learning.

Imaging the calcified lesions: what you need to see

20 May 2026 – From EuroPCR 2026

This session emphasizes critical imaging aspects necessary for assessing calcified coronary lesions. It addresses lesion-specific Agatston scoring, OCT-guided PCI optimization, coronary CT planning, histopathological insights, and predictors of stent underexpansion after calcium modification.

Major Late-Breaking Trials from EuroPCR 2026

20 May 2026 – From EuroPCR 2026

This session presents major late-breaking trials from EuroPCR 2026, reviewing contemporary evidence on coronary revascularization in TAVI patients, long-term outcomes of PCI versus CABG for left main disease, and comparative effectiveness of LAA closure versus NOAC in atrial fibrillation across age groups, with clinical practice implications.

Major Late-Breaking Trials from EuroPCR 2026

Transcatheter mitral interventions: outcomes and new procedural approaches

20 May 2026 – From EuroPCR 2026

This session covers transcatheter mitral interventions, comparing surgical and transcatheter approaches, including TEER and TMVR. It presents clinical outcomes, safety data, and innovative procedural techniques such as transeptal BATMAN to prevent left ventricular outflow tract obstruction during TMVR.

Transcatheter mitral interventions: outcomes and new procedural approaches

Debate: how will AI change the cardiology landscape in the next five years?

20 May 2026 – From EuroPCR 2026

Delve into the anticipated impact of artificial intelligence on cardiology over the next five years. This session addresses AI's role in reporting, triage, workflow optimization, and decision-making, while distinguishing realistic clinical benefits from hype. It also discusses governance, accountability, and legal considerations surrounding AI adoption in...

Structural heart devices: what's new and how it reaches your cathlab

20 May 2026 – From EuroPCR 2026

Discover the latest innovations in structural heart devices, spanning new TAVR platforms, mitral and tricuspid valve technologies, leaflet modification, and closure devices. Gain insight into the comprehensive innovation pathway from concept and prototyping to regulatory approval and clinical adoption, with perspectives from physician-innovators on drivers of...

TAVI procedural complications - Part 5: vascular complications, coronary issues and more

20 May 2026 – From EuroPCR 2026

This session addresses procedural complications during TAVI, focusing on vascular complications, coronary issues, and rare device-related events. It includes case analyses of aortic dissection, valve infolding, stent dislodgement, and management strategies for complex anatomical challenges.

TAVI procedural complications - Part 5: vascular complications, coronary issues and more

Tackling calcified lesions with IVUS guidance and optimisation

20 May 2026 – From EuroPCR 2026

This session delves into the critical role of Intravascular Ultrasound (IVUS) in characterizing and managing calcified coronary lesions. Attendees can explore an imaging-guided approach to calcium treatment, including case presentations that demonstrate stent selection and procedural optimization. Emphasis is placed on applying imaging-based optimization metrics to...

Tackling calcified lesions with IVUS guidance and optimisation

Managing complications in STEMI: always possible?

20 May 2026 – From EuroPCR 2026

This session delves into the complexities of managing complications during STEMI interventions. Through real-world cases from Algeria, Malaysia, and Pakistan, it provides comprehensive analyses of challenging scenarios, treatment strategies, and key learnings, emphasizing the critical decision-making required to navigate complications and improve patient outcomes in high-stakes...

When to best combine guided-directed medical therapy and devices at discharge of acute heart failure

20 May 2026 – From EuroPCR 2026

This session addresses the challenges and strategies in optimizing guided-directed medical therapy for acute heart failure patients, especially those intolerant to up-titration. It also covers the assessment and timing for cardiac resynchronisation therapy (CRT), highlighting the benefits of combining medical therapy and device implantation to improve...

When to best combine guided-directed medical therapy and devices at discharge of acute heart failure

The dark side of calcium: complications, crashes and comebacks

20 May 2026 – From EuroPCR 2026

Focused on the formidable challenges posed by coronary calcium, this session presents three compelling cases illustrating complications, procedural crashes, and successful recoveries. Participants learn detailed approaches to treating PCI complications related to calcified lesions and develop a skillset aimed at prevention and effective management of these...

Registries and trials in mitral TEER

20 May 2026 – From EuroPCR 2026

This comprehensive session reviews registries and clinical trials in mitral transcatheter edge-to-edge repair (TEER). It includes discussions on novel TEER systems, international consensus on PASCAL implants, anatomical predictors of procedural success, and long-term outcomes including ventricular and atrial remodeling after intervention, as well as emerging therapies...

Didn’t find what you were looking for?